Fennec Pharmaceuticals (FENC) Gains from Investment Securities (2018 - 2025)
Fennec Pharmaceuticals posted quarterly Gains from Investment Securities of -$159000.0 for Q4 2025, down 337.31% year-on-year from $67000.0 in Q4 2024, and down 612.9% on a QoQ basis from $31000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 8 years of Gains from Investment Securities data on file, last reported at -$159000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 337.31% year-over-year to -$159000.0; the trailing twelve-month figure through Dec 2025 stood at -$46000.0 (down 132.17% YoY), and the FY2025 full-year result was $283000.0, down 10.44% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$159000.0, down from $31000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $5.0 million in Q3 2023 and bottomed at -$159000.0 in Q4 2025.
- The 5-year median for Gains from Investment Securities is $111500.0 (2024), against an average of $1.5 million.
- The widest annual swing landed in 2022, when Gains from Investment Securities jumped 8574.0%; it then plunged 337.31% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $4.3 million in 2021, then slumped by 99.34% to $28000.0 in 2022, then grew by 25.0% to $35000.0 in 2023, then soared by 91.43% to $67000.0 in 2024, then slumped by 337.31% to -$159000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$159000.0 (Q4 2025), $31000.0 (Q3 2025), and $100000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -159,000.00 |
| Dec 31, 2025 | -159,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 123,000.00 |
| Mar 31, 2025 | 123,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 276,000.00 |
| Sep 30, 2024 | 276,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Sep 30, 2023 | 5.01 Mn |
| Sep 30, 2023 | 5.01 Mn |
| Jun 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 4.89 Mn |
| Mar 31, 2023 | 30,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Sep 30, 2022 | 4.47 Mn |
| Sep 30, 2022 | 4.47 Mn |
| Jun 30, 2022 | 4.34 Mn |
| Jun 30, 2022 | 4.34 Mn |
| Mar 31, 2022 | 382,000.00 |
| Mar 31, 2022 | 382,000.00 |
| Dec 31, 2021 | 4.26 Mn |
| Dec 31, 2021 | 4.26 Mn |
| Sep 30, 2021 | 3.65 Mn |
| Sep 30, 2021 | 3.65 Mn |
| Jun 30, 2021 | 50,000.00 |
| Jun 30, 2021 | 50,000.00 |
| Mar 31, 2021 | 2.95 Mn |
| Mar 31, 2021 | 2.95 Mn |
| Jun 30, 2020 | 648,000.00 |
| Jun 30, 2020 | 648,000.00 |
| Mar 31, 2020 | 648,000.00 |
| Mar 31, 2020 | 648,000.00 |
| Dec 31, 2019 | 648,000.00 |
| Dec 31, 2019 | 648,000.00 |
| Sep 30, 2019 | 175,000.00 |
| Sep 30, 2019 | 175,000.00 |
| Jun 30, 2019 | 648,000.00 |
| Jun 30, 2019 | 648,000.00 |
| Mar 31, 2019 | 648,000.00 |
| Mar 31, 2019 | 648,000.00 |
| Dec 31, 2018 | 648,000.00 |
| Dec 31, 2018 | 648,000.00 |